CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $80 | +6.7% | 3,705 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $75 | -99.9% | 3,705 | 0.0% | 0.00% | -25.0% |
Q3 2022 | $95,000 | -20.2% | 3,705 | -38.4% | 0.00% | 0.0% |
Q4 2021 | $119,000 | -40.8% | 6,010 | -41.1% | 0.00% | -42.9% |
Q3 2021 | $201,000 | -10.3% | 10,200 | 0.0% | 0.01% | -12.5% |
Q2 2021 | $224,000 | -7.8% | 10,200 | 0.0% | 0.01% | -11.1% |
Q1 2021 | $243,000 | -9.0% | 10,200 | 0.0% | 0.01% | -18.2% |
Q4 2020 | $267,000 | +50.0% | 10,200 | 0.0% | 0.01% | +37.5% |
Q3 2020 | $178,000 | +3.5% | 10,200 | 0.0% | 0.01% | -11.1% |
Q2 2020 | $172,000 | – | 10,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |